SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-233052
Filing Date
2023-09-12
Accepted
2023-09-12 08:02:58
Documents
3
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 6-K d471829d6k.htm 6-K 9830
2 EX-99.1 d471829dex991.htm EX-99.1 13157
3 GRAPHIC g471829g0911070105716.jpg GRAPHIC 3351
  Complete submission text file 0001193125-23-233052.txt   28874
Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4
Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 231249052
SIC: 2834 Pharmaceutical Preparations